Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis

American Journal of Veterinary Research

Volumn 69, Issue 7, 2008, Pages 928-937

  Nixon, Alan J ^a   Dahlgren, Linda A ^a,b   Haupt, Jennifer L ^a   Yeager, Amy E ^a   Ward, Daniel L ^b  

^a Department of Obstetrics Gynecology   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE; DNA; PHOSPHATE BUFFERED SALINE; PROTEOGLYCAN; SOMATOMEDIN C;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CELL FRACTIONATION; CELL INFILTRATION; CELL TRANSPLANTATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ECHOGRAPHY; FLEXOR TENDON; FORELIMB; GENE EXPRESSION; HEALING; HISTOLOGY; HORSE; INFLAMMATORY CELL; NONHUMAN; TENDINITIS; TISSUE REPAIR; VASCULARIZATION;

ADIPOSE TISSUE; ANIMALS; CELL TRANSPLANTATION; COLLAGEN TYPE I; COLLAGEN TYPE III; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HORSE DISEASES; HORSES; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; PROTEOGLYCANS; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TENDINOPATHY;

ANIMALIA; EQUIDAE;

EID: 48049104541     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.7.928     Document Type: Article

References (71)

1. Kasashima Y, Takahashi T, Smith RK, et al. Prevalence of superficial digital flexor tendonitis and suspensory desmitis in Japanese Thoroughbred flat racehorses in 1999. Equine Vet J 2004; 36:346-350.
2. Rossdale PD, Hopes R, Wingfield-Digby NJ, et al. Epidemiological study of wastage among racehorses in 1982 and 1983. Vet Rec 1985;116:66-69.
3. Goodship AE, Birch HL, Wilson AM. The pathobiology and repair of tendon and ligament injury. Vet Clin North Am Equine Pract 1994;10:323-349.
4. Genovese RL. Prognosis of superficial flexor tendon and suspensory ligament injuries, in Proceedings. 39th Annu Conv Am Assoc Equine Pract 1993;17-19.
5. Rooney JR, Genovese RL. A survey and analysis of bowed tendon in Thoroughbred racehorses. Equine Vet Sci 1981;1:49-53.
6. Dyson SJ. Treatment of superficial digital flexor tendinitis: a comparison of conservative management, sodium hyaluronate, and glycosaminoglycan polysulfate, in Proceedings. 43rd Annu Conv Am Assoc Equine Pract 1997;297-300.
7. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000). Equine Vet J 2004;36:415-419.
8. Bramlage LR, Hogan PM. Career results of 137 Thoroughbred racehorses that have undergone superior check ligament desmotomy for treatment of tendinitis, in Proceedings. 42nd Annu Conv Am Assoc Equine Pract 1996;162-163.
9. Foland J, Trotter GW, Powers BE, et al. Effect of sodium hyaluronate in collagenase-induced superficial digital flexor tendinitis in horses. Am J Vet Res 1992;53:2371-2376.
10. Gaughan EM, Gift LJ, De Bowes RM, et al. The influence of sequential intratendinous sodium hyaluronate on tendon healing in horses. Vet Comp Orthop Traumatol 1995;8:40-45.
11. Gift LJ, Gaughan EM, DeBowes RM, et al, The influence of intratendinous sodium hyaluronate on tendon healing in horses. Vet Comp Orthop Traumatol 1992;4:151-157.
12. Henninger RW, Bramlage LR, Bailey M, et al. Effects of tendon splitting on experimentally-induced acute equine tendinitis. Vet Comp Orthop Traumatol 1992;5:1-9.
13. Ferraro GL. Lameness diagnosis and treatment in the Thoroughbred racehorse. Vet Clin North Am Equine Pract 1990;6:63-84.
14. Gillis C. Tendon and ligament rehabilitation, in Proceedings. Dubai Int Equine Symp 1996;417-421.
15. Hogan PM, Bramlage LR. Transection of the accessory ligament of the superficial digital flexor tendon for treatment of tendinitis: long term results in 61 Standardbred racehorses (1985-1992). Equine Vet J 1995;27:221-226.
16. Fulton IC, Maclean AA, O'Reilly JL, et al. Superior check ligament desmotomy for treatment of superficial digital flexor tendonitis in Thoroughbred and Standardbred horses. Aust Vet J 1994;71:233-235.
17. Stashak TS. Management of wounds associated with tendons, paratendons, and tendon sheaths. In: Stashak TS, ed. Equine wound management. Philadelphia: Lea & Febiger, 1991;238-257.
18. Murphy DJ, Nixon AJ. Biochemical and site-specific effects of insulin-like growth factor I on intrinsic tenocyte activity in equine flexor tendons. Am J Vet Res 1997;58:103-109.
19. Zaidi N, Nixon AJ. Stem cell therapy in bone repair and regeneration. Ann N Y Acad Sci 2007;1117:62-72.
20. Young RG, Butler DL, Weber W, et al. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1998;16:406-413.
21. Bruder SP, Kraus KH, Goldberg VM, et al. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998;80:985-996.
22. Smith RK, Korda M, Blunn GW, et al. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J 2003;35:99-102.
23. Di RG, Iachininoto MG, Tritarelli A, et al. Myogenic potential of adipose-tissue-derived cells. J Cell Sci 2006;119:2945-2952.
24. Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005;54:132-141.
25. Bosnakovski D, Mizuno M, Kim G, et al. Isolation and multilineage differentiation of bovine bone marrow mesenchymal stem cells. Cell Tissue Res 2005;319:243-253.
26. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004;8:301-316.
27. Caplan AI. Review: mesenchymal stem cells: cell-based econstructive therapy in orthopedics. Tissue Eng 2005;11:1198-1211.
28. Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. Stem Cells 2004;22:487-500.
29. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74.
30. Zuk PA, Benhaim P, Hedrick MH. Stem cells from adipose tissue. In: Lanzer R, Blau H, Melton D, et al, eds. Handbook of stem cells. Volume 2. Adult and fetal stem cells. New York: Academic Press Inc, 2004;425-447.
31. Bi Y, Ehirchiou D, Kilts TM, et al. Identification of tendon stem/ progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007;13:1219-1227.
32. Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic transplants of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;6:230-247.
33. Zuk PA. Stem cell research has only just begun. Science 2001;293:211-212.
34. Durando MM, Zarucco L, Schaer TP, et al. Pneumopericardium in a horse secondary to sternal bone marrow aspiration. Equine Vet Educ 2006;2:75-79.
35. Fortier LA, Nixon AJ, Williams J, et al. Isolation and chondrocytic differentiation of equine bone marrow-derived mesenchymal stem cells. Am J Vet Res 1998;59:1182-1187.
36. Wilke MM, Nydam D, Nixon AJ. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 2007;25:913-925.
37. Herthel DJ. Enhanced suspensory ligament healing in 100 horses by stem cell and other bone marrow components, in Proceedings. 47th Annu Conv Am Assoc Equine Pract 2001;319-321.
38. Smith RK, Webbon PM. Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn? Br J Sports Med 2005;39:582-584.
39. Strem BM, Hedrick MH. The growing importance of fat in regenerative medicine. Trends Biotechnol 2005;23:64-66.
40. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
41. Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006;24:150-154.
42. Nathan S, Das DS, Thambyah A, et al. Cell-based therapy in the repair of osteochondral defects: a novel use for adipose tissue. Tissue Eng 2003;9:733-744.
43. Cowan CM, Shi YY, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004;22:560-567.
44. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004;109:1292-1298.
45. Williams IF, McCullagh GD, Goodship AE, et al. Studies on the pathogenesis of equine tendinitis following collagenase injury. Res Vet Sci 1984;36:326-338.
46. Redding WR, Booth LC, Pool RR. The effects of polysulphated glycosaminoglycan on the healing of collagenase-induced tendinitis. Vet Comp Orthop Traumatol 1999;12:48-55.
47. Keg PR, van den Belt AJM, Merkens HW, et al. The effect of regional nerve blocks on the lameness caused by collagenase induced tendonitis in the midmetacarpal region of the horse: a study using gait analysis and ultrasonography to determine tendon healing. Zentralbl Veterinarmed A 1992;39:349-364.
48. Dowling BA, Dart AJ, Hodgson DR, et al. The effect of recombinant equine growth hormone on the biomechanical properties of healing superficial digital flexor tendons in horses. Vet Surg 2002;31:320-324.
49. Dahlgren LA, Brower-Toland BD, Nixon AJ. Cloning and expression of type III collagen in normal and injured tendons of horses. Am J Vet Res 2005;66:266-270.
50. Dahlgren LA, Mohammed HO, Nixon AJ. Temporal expression of growth factors and matrix molecules in healing tendon lesions. J Orthop Res 2005;23:84-92.
51. Dahlgren LA, van der Meulen MC, Bertram JE, et al. Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendinitis. J Orthop Res 2002;20:910-919.
52. Reef VB. Musculoskeletal ultrasonography. In: Reef VB, ed. Equine diagnostic ultrasound. Philadelphia: WB Saunders Co, 1998;39-186.
53. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-228.
54. Goodrich LR, Hidaka C, Robbins PD, et al. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br 2007;89:672-685.
55. Nixon AJ, Haupt JL, Frisbie DD, et al. Gene mediated restoration of cartilage matrix by combination insulin-like growth factor-1/ interleukin-1 receptor antagonist therapy. Gene Ther 2005;12:177-186.
56. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883:173-177.
57. Kim Y-J, Sah RLY, Doong J-YH, et al. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 1988;174:168-176.
58. Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005;129:118-129.
59. Wolbank S, Peterbauer A, Fahrner M, et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 2007;13:1173-1183.
60. Butler DL, Juncosa-Melvin N, Boivin GP, et al. Functional tissue engineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation. J Orthop Res 2008;26:1-9.
61. Diefenderfer DL, Brighton CT. Microvascular pericytes express aggrecan message which is regulated by BMP-2. Biochem Biophys Res Commun 2000;269:172-178.
62. Lin Y, Chen X, Yah Z, et al. Multilineage differentiation of adipose-derived stromal cells from GFP transgenic mice. Mol Cell Biochem 2006;285:69-78.
63. Fang B, Song YP, Liao LM, et al. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 2006;38:389-390.
64. Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med 2003;33:381-394.
65. Anitua E, Andia I, Sanchez M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005;23:281-286.
66. Awad HA, Butler DL, Boivin GP, et al. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng 1999;5:267-277.
67. Rosenberg K, Olsson H, Morgelin M, et al. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem 1998;273:20397-20403.
68. Sodersten F, Ekman S, Eloranta ML, et al. Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in relation to collagen fibrils in the equine tendon. Matrix Biol 2005;24:376-385.
69. Smith RKW, Zunino L, Webbon PM, et al. The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 1997;16:255-271.
70. Smith RK, Birch HL, Goodman S, et al. The influence of ageing and exercise on tendon growth and degeneration - hypotheses for the initiation and prevention of strain-induced tendinopathies. Comp Biochem Physiol A Mol Integr Physiol 2002;133:1039-1050.
71. Nixon AJ. Stem cell research: where are we enhancing healing?, in Proceedings. 13th Annu Symp Am Coll Vet Surg 2003;1-4.